Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Aerogen Pharma Limited

Clinical trials sponsored by Aerogen Pharma Limited, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New inhaled therapy could help preterm infants breathe easier Results expected May 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New inhaled therapy could help preterm infants breathe easier

    Disease control Recruiting now

    This Phase 3 trial tests a new inhaled medication called APC-0101 in 520 premature babies born between 26 and 33 weeks who have respiratory distress syndrome. The drug is a surfactant that helps keep tiny air sacs in the lungs open. Some babies receive the active drug through a s…

    Phase 3 • Sponsor: Aerogen Pharma Limited • Aim: Disease control

    Last updated Aug 08, 2026 00:03 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space